Ribupatide is still being trialled in the UK, but some participants in a trial at Shanghai’s Fudan University lost nearly a fifth of their body weight in 11 months
New Chinese jab could rival popular weight-loss drugs like Wegovy and Mounjaro


Ribupatide is still being trialled in the UK, but some participants in a trial at Shanghai’s Fudan University lost nearly a fifth of their body weight in 11 months